Clinical Trial Update: CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma [NA]

View source ↗

Summary

Clinical trial update for a CAR-T therapy sponsored by Sinobioway Cell Therapy Co., Ltd. The study aims to evaluate safety and effectiveness in lymphoma, but th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• CAR-T therapy (Chimeric antigen receptor T-cell therapy)

Snippet

Sponsor: Sinobioway Cell Therapy Co., Ltd. | Conditions: Lymphoma | NA | Status: UNKNOWN